Successful Treatment of Epidermolysis Bullosa Pruriginosa With Topical Tacrolimus
Open Access
- 1 July 2004
- journal article
- case report
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 140 (7) , 794
- https://doi.org/10.1001/archderm.140.7.794
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A Novel Splice Site Mutation in Collagen Type VII Gene in a Chinese Family with Dominant Dystrophic Epidermolysis Bullosa PruriginosaActa Dermato-Venereologica, 2002
- The clinical spectrum of dystrophic epidermolysis bullosaBritish Journal of Dermatology, 2002
- Tacrolimus ointment for the treatment of steroid-induced rosacea: A preliminary reportJournal of the American Academy of Dermatology, 2001
- Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part I, efficacyJournal of the American Academy of Dermatology, 2001
- Safety and Efficacy of 1 Year of Tacrolimus Ointment Monotherapy in Adults With Atopic DermatitisArchives of Dermatology, 2000
- Allelic Heterogeneity of Dominant and Recessive COL7A1 Mutations Underlying Epidermolysis Bullosa PruriginosaJournal of Investigative Dermatology, 1999
- A Short-Term Trial of Tacrolimus Ointment for Atopic DermatitisNew England Journal of Medicine, 1997
- A Glycine-to-Arginine Substitution in the Triple-Helical Domain of Type VII Collagen in a Family with Dominant Dystrophic Epidermolysis Bullosa PruriginosaJournal of Investigative Dermatology, 1997
- Epidermolysis bullosa pruriginosa: dystrophic epidermolysis bullosa with distinctive clinicopathological featuresBritish Journal of Dermatology, 1994
- Anti-Inflammatory Effect of FK-506 on Human Skin Mast CellsJournal of Investigative Dermatology, 1992